Recombinant multi-species WASL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WASL protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the Wiskott-Aldrich syndrome (WAS) protein family. Wiskott-Aldrich syndrome proteins share similar domain structure, and associate with a variety of signaling molecules to alter the actin cytoskeleton. The encoded protein is highly expressed in neural tissues, and interacts with several proteins involved in cytoskeletal organization, including cell division control protein 42 (CDC42) and the actin-related protein-2/3 (ARP2/3) complex. The encoded protein may be involved in the formation of long actin microspikes, and in neurite extension. [provided by RefSeq, Jul 2013]
The Alternative Names of target: 2900021I12Rik,3110031I02Rik,Actin nucleation-promoting factor WASL,N-WASP,NWASP,Neural Wiskott-Aldrich syndrome protein (N-WASP),TRS4,WASL,WASPB,Wasl

Target products collectionGo to WASL products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP13349-Ag-1/ GM-Tg-hg-IP13349-Ag-2 Human WASL protein Human
GM-Tg-rg-IP13349-Ag-1/ GM-Tg-rg-IP13349-Ag-2 Rat WASL protein Rat
GM-Tg-mg-IP13349-Ag-1/ GM-Tg-mg-IP13349-Ag-2 Mouse WASL protein Mouse
GM-Tg-cynog-IP13349-Ag-1/ GM-Tg-cynog-IP13349-Ag-2 Cynomolgus/Rhesus macaque WASL protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP13349-Ag-1/ GM-Tg-felg-IP13349-Ag-2 Feline WASL protein Feline
GM-Tg-cang-IP13349-Ag-1/ GM-Tg-cang-IP13349-Ag-2 Canine WASL protein Canine
GM-Tg-bovg-IP13349-Ag-1/ GM-Tg-bovg-IP13349-Ag-2 Bovine WASL protein Bovine
GM-Tg-equg-IP13349-Ag-1/ GM-Tg-equg-IP13349-Ag-2 Equine WASL protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP13349-Ag-1/ GM-Tg-hg-IP13349-Ag-2; GM-Tg-rg-IP13349-Ag-1/ GM-Tg-rg-IP13349-Ag-2;
GM-Tg-mg-IP13349-Ag-1/ GM-Tg-mg-IP13349-Ag-2; GM-Tg-cynog-IP13349-Ag-1/ GM-Tg-cynog-IP13349-Ag-2;
GM-Tg-felg-IP13349-Ag-1/ GM-Tg-felg-IP13349-Ag-2; GM-Tg-cang-IP13349-Ag-1/ GM-Tg-cang-IP13349-Ag-2;
GM-Tg-bovg-IP13349-Ag-1/ GM-Tg-bovg-IP13349-Ag-2; GM-Tg-equg-IP13349-Ag-1/ GM-Tg-equg-IP13349-Ag-2
Products Name WASL protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name WASL
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine WASL protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.